Trial Details
COMPLETEDBasic Information
| Clinical ID | c2320 |
|---|---|
| Identifier | NCT03677648 |
| Trial Title | A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: SHR0302|DRUG: Placebos |
Participant Information
| Sponsor | Reistone Biopharma Company Limited |
|---|---|
| City | Clearwater |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-05-14 |
|---|---|
| Primary Completion Date | 2021-09-16 |
| Completion Date | 2021-12-09 |